Literature DB >> 30788853

Physical exercise and Prader-Willi syndrome: A systematic review.

Javier S Morales1, Pedro L Valenzuela2,3, Helios Pareja-Galeano1,4, Cecilia Rincón-Castanedo1, Daniela A Rubin5, Alejandro Lucia1,4.   

Abstract

OBJECTIVE: The aim of this systematic review was to summarize evidence on the acute responses of individuals with Prader-Willi syndrome (PWS) to physical exercise, and on the effectiveness of long-term exercise interventions to improve the clinical manifestations of this syndrome. DESIGN/
METHODS: Relevant articles were identified in the electronic databases PubMed, Medline, CINAHL and SPORTDiscus (from inception to December 2018). Twenty-two studies including a total of 356 patients with PWS met all inclusion criteria and were included in the review.
RESULTS: Patients with PWS present with a decreased physical performance and impaired cardiorespiratory (maximal oxygen consumption, heart rate recovery after exercise) and hormonal (growth hormone release) responses to exercise. Most long-term exercise interventions have proven to decrease body mass while improving physical performance. Some benefits have also been reported in biochemical (glucose homeostasis, lipid profile) and biomechanical (gait pattern) variables, although there is controversy regarding the effects on body composition. No exercise-related adverse events have been reported in patients with PWS.
CONCLUSION: Physical exercise seems to be safe and effective for improving several phenotypes in PWS, notably physical fitness. However, further research is needed to confirm these results and especially to corroborate whether exercise per se or combined with dietary intervention is an effective coadjuvant treatment for reducing body mass in these patients.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  body composition; fitness; genetic syndrome; growth hormone; metabolic response; obesity; physical activity

Mesh:

Year:  2019        PMID: 30788853     DOI: 10.1111/cen.13953

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Health Problems in Individuals With PWS Are Associated With Lower Quality of Life for Their Parents: A Snapshot in the Brazilian Population.

Authors:  Alexandre Slowetzky Amaro; Daniela Andrea Rubin; Maria Cristina Triguero Veloz Teixeira; Arcenio José Ferreira; Graciele Massoli Rodrigues; Luiz Renato Rodrigues Carreiro
Journal:  Front Pediatr       Date:  2022-02-15       Impact factor: 3.418

2.  Dietary Conjugated Linoleic Acid Reduces Body Weight and Fat in Snord116m+/p- and Snord116m-/p- Mouse Models of Prader-Willi Syndrome.

Authors:  Brittney Knott; Matthew A Kocher; Henry A Paz; Shelby E Hamm; William Fink; Jordan Mason; Robert W Grange; Umesh D Wankhade; Deborah J Good
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

3.  Efficacy of empagliflozin for weight and glycemic control of a patient with Prader-Willi syndrome, systemic lymphedema and extreme obesity: a case report.

Authors:  Juliano Boufleur Farinha; Letícia Schwerz Weinert; Lidiane Pozza Costa; Marcelo Zanusso Costa; Patrícia Peres de Peres; Cláudia Fernandes Lorea
Journal:  Int J Diabetes Dev Ctries       Date:  2022-04-27

4.  Accelerometer-Measured Physical Activity and Sedentary Behavior of Adults with Prader-Willi Syndrome Attending and Not Attending a Small-Scale Community Workshop.

Authors:  Ming-Ju Wu; Li-Ping Tsai; Ting-Fu Lai; Jeong Su Cho; Yung Liao
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.